Title : PARP inhibitor olaparib has a potential to increase the effectiveness of electrochemotherapy in BRCA1 mutated breast cancer in mice.

Pub. Date : 2021 Aug

PMID : 33984694






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Combined therapy of ECT with bleomycin and olaparib potentiated the effectiveness of ECT in BRCA1 mutated HCC1937, but not in non-mutated HCC1143 cells. Bleomycin BRCA1 DNA repair associated Homo sapiens